首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Uromodulin, an emerging novel pathway for blood pressure regulation and hypertension.
【24h】

Uromodulin, an emerging novel pathway for blood pressure regulation and hypertension.

机译:尿调节蛋白,一种新兴的血压调节和高血压新途径。

获取原文
获取原文并翻译 | 示例
           

摘要

Leigh syndrome (MIM 25600), also known as infantile subacute necrotizing encephalomyelopathy, is a neurodegenerative disorder with characteristic bilateral symmetric lesions in basal ganglia and subcortical brain regions. It is commonly associated with systemic cytochrome c oxidase (COX) deficiency and mutations in the SURF1 gene (MIM 185620), encoding a putative assembly or maintenance factor of COX. The clinical course is dominated by neurodevelopmental regression, brain stem, and basal ganglia involvement (e.g., dystonia, apnea) with death often occurring before the age of 10 years. Herein, we present three sisters carrying a previously reported homozygous SURF1 mutation (c.868_869insT) that is predicted to result in a truncated protein with loss of function. Our patients show heterogeneous clinical findings with different distribution patterns of metabolic lesions in brain magnetic resonance imaging (MRI) as well as a Chiari malformation with hydrocephalus in one patient. However, all three siblings show an unusual long survival (12 years and>16 years). COX activity was not detectable in one patient and strongly reduced in the other two. We discuss these findings with respect to a review of the literature. A total of 15 additional patients with survival>14 years have been reported so far. Overall, no clear genotype-phenotype correlations are detectable among these patients.
机译:Leigh综合征(MIM 25600),也称为婴儿亚急性坏死性脑脊髓病,是一种神经退行性疾病,在基底神经节和皮层下大脑区域具有典型的双侧对称性病变。它通常与系统性细胞色素C氧化酶(COX)缺乏和SURF1基因(MIM 185620)中的突变相关,编码一个假定的COX装配或维持因子。临床过程主要由神经发育退化,脑干和基底神经节受累(例如肌张力障碍,呼吸暂停)引起,死亡通常发生在10岁之前。在本文中,我们介绍了三个姐妹,它们携带先前报道的纯合SURF1突变(c.868_869insT),预计会导致截短的蛋白丧失功能。我们的患者在脑磁共振成像(MRI)中表现出异质性的临床表现,并具有不同的代谢病变分布模式,其中一名患者患有脑积水的Chiari畸形。但是,所有三个兄弟姐妹都表现出不同寻常的长生存期(12年和> 16年)。一名患者无法检测到COX活性,而其他两名患者则明显降低。我们结合文献综述来讨论这些发现。迄今为止,总共报告了另外15例生存期> 14年的患者。总体而言,在这些患者中没有明显的基因型-表型相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号